The Peptide NewsroomPeptide research, industry and supply-chain headlines

Perelel Pairs Collagen Peptides With Lactoferrin, But the Immune Claim Has No Published Study

Topic card: collagen supply

Us Weekly has written up Perelel Collagen+ Defense, a new daily powder that pairs collagen peptides with animal-free lactoferrin and is pitched at cold and flu season. The write-up carries an affiliate disclosure, which is worth knowing before you read the word "immunity" anywhere near it.

The two named ingredients are the reason this is our story. Lactoferrin is an iron-binding protein, and the collagen here is hydrolyzed bovine collagen, meaning the protein has been broken into shorter peptide chains before it reaches the tub.

What is actually in the scoop

Perelel lists 10 grams of hydrolyzed bovine collagen peptides and one gram of lactoferrin per serving, with each container holding a 25-day supply. The brand says lactoferrin supports everyday immune health in as little as three weeks, and that collagen peptides provide structural support for joints and connective tissue.

Those are the brand's own framings, not findings from a trial. Us Weekly repeats them with a caveat of its own, noting they are intended wellness benefits rather than protection against seasonal illness.

Where the evidence stops

No study is named anywhere in the coverage. There is no trial, no participant count, no published data behind the three-week figure, and the formula is described only as developed by doctors and nutritionists, which is a credentialing claim rather than an evidence one.

That matters more than usual because the hook is seasonal immunity, the single hardest consumer-supplement claim to support. A three-week timeline is specific enough to sound like it came from somewhere, and the article never says where.

The convenience pitch

The practical argument is the strongest one in the piece: the powder is unflavored and mixes into coffee, smoothies or water, so it attaches to a routine someone already has. That is a real advantage over a product requiring its own step, and it is most of why collagen powders keep selling.

Perelel was founded in 2020 by Victoria Thain Gioia, Alex Taylor and OB/GYN Dr. Banafsheh Bayati, starting with prenatal vitamins and expanding into supplements aimed at pregnancy, postpartum and perimenopause. Collagen+ Defense fits that pattern of bundling several wellness goals into one formula.

The open question

The interesting question is not whether lactoferrin is a plausible ingredient, because it is. It is whether a one-gram daily dose does anything measurable in three weeks, and until Perelel publishes something, nobody reading a shopping page can tell.

Source: Us Weekly. Read the original.

Filed under: collagen, supply

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Yak Collagen Peptides Blocked MMP-1 in Lab Tests, But the Lifespan Data Is All Worms

A study in npj Science of Food reports that three peptides screened from yak bone collagen inhibited MMP-1 in laboratory assays and extended lifespan in nematodes. The researchers say the work does not demonstrate anti-aging benefits, safety or efficacy in humans.

Jessica Pegula Names Collagen Peptides a Daily Staple, But the Evidence Is Hers Alone

Tennis player Jessica Pegula named collagen peptides among her six daily must-haves in a Page Six Style interview, alongside sunscreen and a recovery tracker. She also has a partnership with the collagen brand she named, and the piece cites no study or outcome figure at all.

Collagen Peptides May Help Tendons Adapt, But Whey Still Wins on Muscle Size

A ZME Science feature weighs the fitness industry's peptide claims against the trial data, finding whey ahead of collagen on muscle size but a real signal for collagen on tendon adaptation. Much of the supporting evidence is rated low certainty, and injury prevention remains unestablished.